XNCR
XNCR
NASDAQ · Biotechnology

Xencor Inc

$12.13
+0.01 (+0.08%)
As of Mar 22, 10:12 PM ET ·
Analyst Consensus
Strong Buy
20
Analysts
High
Coverage
Buy 18 90%
Hold 2 10%
Sell 0 0%
Price Target
Analyst Price Target +104.2% upside
Low Target $14.60
Average Target $24.77
High Target $27.54
Current Price $12.13
Current
$12.13
Target
$24.77
$14.60 $24.77 avg $27.54
Scenario Analysis
Bear Case
$14.60
20.4%
Low target
Base Case
$24.77
+104.2%
Avg target
Bull Case
$27.54
+127.0%
High target
Risk/Reward
6.2x
Highly favorable
Price in Context
52-Week High
$18.69
-35.1% from high
52-Week Low
$6.92
+75.3% from low
Target vs 52W High
$24.77
+32.5% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Buy 39 69% $257.58 +24.3%
AMGN
Amgen Inc
Hold 42 50% $190.87 -46.1%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +162.3%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 79% $438.34 -3.7%
REGN
Regeneron Pharmaceuticals
Strong Buy 36 75% $76.80 -89.8%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 78% $102.31 -68.9%
INSM
Insmed Inc
Strong Buy 26 92% $143.40 -3.3%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -27.6%